Esketamine Nasal Spray

US FDA approves new nasal spray for depression treatment

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

Hosted on MSN · 6h

Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray,

PopSugar · 21h

Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

HealthDay on MSN21h

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...

23hon MSN

TTUHSC Psychiatry chairman discusses newly approved antidepressant nasal spray

The FDA approved Spravato for those battling depression and has seen little to no improvement from two types of ...

Welcome to The Swamp, Our Newsletter Chronicling Trump’s New Landscape

Cold pressed into bite-sized pieces, Whole Food Clusters are served in a convenient, scoopable format. It’s available in puppy or adult recipes and has three protein options: cage- free chicken, ranch ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

US FDA approves new nasal spray for depression treatment

Trending now

Related topics